You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMRX Exercise Disclosure
Buchi J Kevin · SEC Form 4 · Filed Aug 13, 2026
Exercise
Calculated transaction value
$2.9M
Buchi J Kevin Director
AMRX
Transaction date
Aug 11, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 2 days later
AMRX daily price context
Close on/before transaction
$17.1
Aug 11, 2026
First close after public filing
$18.15
Aug 14, 2026
30-day return after filing
-5.12%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 168,573 shares @ $17.18
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-056752
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$2.9M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. AMRX Current | Exercise | Aug 11, 2026 | $2.9M |